OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 78 filers reported holding OCULAR THERAPEUTIX INC in Q4 2016. The put-call ratio across all filers is 0.58 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $4,809,000 | -15.1% | 574,555 | -30.3% | 0.00% | 0.0% |
| Q3 2016 | $5,664,000 | +47.5% | 824,426 | +6.3% | 0.00% | 0.0% |
| Q2 2016 | $3,839,000 | -43.5% | 775,611 | +10.2% | 0.00% | -50.0% |
| Q1 2016 | $6,798,000 | +4.6% | 703,729 | +1.5% | 0.00% | +100.0% |
| Q4 2015 | $6,497,000 | +17.7% | 693,409 | +76.7% | 0.00% | 0.0% |
| Q3 2015 | $5,518,000 | -24.0% | 392,453 | +13.6% | 0.00% | -50.0% |
| Q2 2015 | $7,262,000 | +6.7% | 345,336 | +113.0% | 0.00% | 0.0% |
| Q1 2015 | $6,806,000 | +83.5% | 162,100 | +2.8% | 0.00% | +100.0% |
| Q4 2014 | $3,710,000 | +75.1% | 157,739 | +11.4% | 0.00% | 0.0% |
| Q3 2014 | $2,119,000 | – | 141,562 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 3,804,788 | $15,105,000 | 43.34% |
| Versant Venture Management, LLC | 2,215,384 | $8,795,074,000 | 2.90% |
| Opaleye Management Inc. | 1,900,000 | $7,543,000 | 2.09% |
| SV Health Investors, LLC | 628,236 | $2,494,000 | 1.46% |
| Endurant Capital Management LP | 716,124 | $2,843,000 | 1.12% |
| DELTEC ASSET MANAGEMENT LLC | 824,747 | $3,274,000 | 0.72% |
| NOTTINGHAM ADVISORS, INC. | 146,946 | $583,000 | 0.08% |
| Jump Trading, LLC | 39,255 | $156,000 | 0.05% |
| Man Group plc | 1,723,456 | $6,842,000 | 0.03% |
| JGP Global Gestao de Recursos Ltda. | 13,880 | $55,000 | 0.02% |